Clinical trials
Terminated Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
242 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 10 |
| 2006 | 9 |
| 2007 | 19 |
| 2008 | 21 |
| 2009 | 15 |
| 2010 | 7 |
| 2011 | 15 |
| 2012 | 13 |
| 2013 | 13 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 15 |
| 2018 | 14 |
| 2019 | 14 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 242 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Mental Health (NIMH) | 9 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 |
| AstraZeneca | 7 |
| Hôpital le Vinatier | 6 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 6 |
| University Hospital, Strasbourg, France | 6 |
| Denovo Biopharma LLC | 5 |
| H. Lundbeck A/S | 5 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 5 |
| Yale University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 242 |
| Psychotic Disorders | 65 |
| Bipolar Disorder | 9 |
| Hallucinations | 8 |
| Mental Disorders | 8 |
| Cognitive Dysfunction | 7 |
| Obesity | 7 |
| Metabolic Syndrome | 5 |
| Cognition Disorders | 4 |
| Weight Gain | 4 |
Trials
Showing 1 to 25 of 242. Each trial links to its page on Pharma Observatory.
142 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.